News
Is DexCom a Millionaire-Maker Stock?
Medical device specialist DexCom (NASDAQ: DXCM) is going through a rough patch. The company's shares dropped off a cliff following its second-quarter earnings report. However, zooming out helps put
Is Medtronic Stock a Buy?
Medical device giant Medtronic (NYSE: MDT) has been somewhat of a stock market laggard over the past five years, partly due to pandemic-related disruptions. Even beyond this global issue, the
Why Insulet Stock Was Zooming Higher This Week
Specialty device maker Insulet (NASDAQ: PODD) had some good news to impart to the world early this week, and investors jumped on the stock as a result. As the market started to prepare for its
VITROS® Syphilis Assay Now Available on VITROS 3600 Immunodiagnostic System, VITROS 5600 and VITROS XT 7600 Integrated Systems in the U.S.
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”) has received U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its VITROS syphilis assay as part of its menu, strengthening
Why Patterson Companies Stock Is Plunging Today
Shares of Patterson Companies (NASDAQ: PDCO) were plunging 15.1% as of 11:09 a.m. ET on Wednesday. The steep decline came after the dental and animal health company announced its fiscal 2025
Methodist and Acadia Healthcare Break Ground on Behavioral Health Hospital in Council Bluffs
Methodist Jennie Edmundson Hospital and Acadia Healthcare Company held a groundbreaking ceremony today for a state-of-the-art behavioral health hospital serving western Iowa and eastern Nebraska
This Is Great News for Medtronic, but Is It Time to Buy the Stock?
Medtronic (NYSE: MDT) posted first-quarter earnings (for the period ended on June 30) that exceeded the average of Wall Street estimates. The results were strong enough for the medical technologies
Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter glucose biosensor in the
Tilray Brands Is Buying More Beer Brands, and Its Wheeling and Dealing Isn't Over
Tilray Brands (NASDAQ: TLRY) is no stranger to acquisitions. That has been a key part of its growth strategy and a way for it to expand its operations over the years. That has allowed it to grow its
PEOPLE Magazine Recognizes Humana as one of the Top “100 Companies That Care”
Humana Inc. (NYSE: HUM), a leading health and well-being company, is proud to announce that it has been named to PEOPLE’s “100 Companies That Care list” for 2024, ranking Humana in the top 50 (46th
Medtronic (MDT) Q1 2025 Earnings Call Transcript
Image source: The Motley Fool.
Medtronic (NYSE: MDT)Q1 2025 Earnings CallAug 20, 2024, 8:00 a.m. ET
Ryan Weispfenning -- Vice President and Head, Investor Relations
Source Fool.com
2 Unstoppable Healthcare Stocks to Buy Right Now With Less Than $200
The stock market remains one of the best ways to grow capital over time. And although having millions in the bank might help, a more accessible -- and perfectly sensible -- strategy is to invest
2 Growth Stocks to Buy at a Discount
If you're looking for stocks on sale in the current market, despite the broader gains that major indices have clocked, many companies have responded in different ways. While a stock trading at a
Why Victoria's Secret Stock Was Soaring This Week
A fresh change in leadership, unexpectedly strong preliminary results, and a set of bullish new analyst notes were the main factors pushing Victoria's Secret (NYSE: VSCO) stock higher in recent
1 Growth Stock Down 43% to Buy Right Now
Attractive investment opportunities can sometimes arise when investors react emotionally to short-term events. Some of these events revolve around the earnings season, when a company releases
Why Victoria's Secret Stock Was Climbing Today
Shares of Victoria's Secret (NYSE: VSCO) were surging today after the struggling apparel company named a new CEO, Hillary Super. Investors seem to be hopeful that the move will lead to a turnaround
RAMQ Expands Provincial Coverage to Include Dexcom G7, Bringing the Next-Generation CGM System to More Québec Residents
Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced today that its latest innovation, the Dexcom G7 Continuous
EQS-News: STRATEC POSTS RESULTS FOR FIRST HALF OF 2024
Should You Buy DexCom Stock After Its Post-Earnings Sell-Off?
When a stock falls over a cliff after earnings, it can put investors into an unnerving situation: Should you average down, or simply get out of the stock entirely? It's not always an easy question
These Stocks Just Dropped by 40% and 15% -- Should You Buy the Dip?
Earnings season can be a volatile time in the stock market. Some corporations produce financial results that are impressive enough to send their share prices soaring, while others move in the exact
EQS-News: First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed
Humana Foundation Announces 2024 Scholarship Awards
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 42 years, today announced 80 winners of college scholarships awarded through the Humana Foundation Scholarship
2 Dividend Stocks to Buy and Never Sell
Every corporation will face challenges and setbacks -- which will sometimes sink its stock price. That's not a good reason for long-term investors to jump ship unless, of course, there's a
Down 40% in 1 Day, Is DexCom Stock Still a Buy?
July 25 was a difficult day for DexCom (NASDAQ: DXCM) shareholders, with the company's second-quarter earnings release crashing the stock by 40%. To make matters worse, at the moment it's unclear
EQS-News: Carl Zeiss Meditec closes first nine months of 2023/24 with slight decline in revenue